Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 14  |  Issue : 56  |  Page : 390-396

Alpha-mangostin suppresses receptor activator nuclear factor-κB ligand-induced osteoclast formation and bone resorption in RAW264.7 cells by inhibiting the extracellular signal-regulated kinase and c-Jun N-terminal kinase signaling


Department of Orthopedic Surgery, Huangyan Hospital, Wenzhou Medical University, Huangyan; Department of Orthopedic Surgery, Taizhou First People's Hospital, Huangyan, Taizhou, Zhejiang 318020, China

Correspondence Address:
Yong-Hua Li
Department of Orthopedic Surgery, Huangyan Hospital, Wenzhou Medical College, Huangyan, Taizhou, Zhejiang 318020
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_203_17

Rights and Permissions

Background: Excessive osteoclast formation and over-activated function lead to a series of osteoclast-related diseases. Suppression of osteoclastogenesis is likely to be an effective means for the treatment of these diseases. Objective: In this study, we investigated the effects of alpha-mangostin (α-MAG), a natural compound derived from Garcinia mangostana, on osteoclast formation and function in RAW264.7 cells. Materials and Methods: Different concentrations of α-MAG were used to explore its effects on receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis and further, we investigated the mechanism by Western Blotting. Results: The study revealed that α-MAG attenuated RANKL-induced osteoclastogenesis. Moreover, the effects were confirmed to be caused by the suppression of the phosphorylation of the extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) signaling and this inhibitory effect could be rescued by the administration of the JNK and p38 agonist anisomycin. Conclusion: The study results demonstrated that α-MAG could impair RANKL-induced osteoclastogenesis by inhibiting the ERK and JNK signaling pathways in RAW264.7 cells. Abbreviations used: α-MAG: α-mangostin, RANKL: Receptor activator of nuclear factor-κB ligand, ERK: Extracellular signal-regulated kinase, JNK: c-Jun N-terminal kinase, ANI: Anisomycin, M-CSF: Macrophage colony-stimulating factor, MAPK: Mitogen-activated protein kinase, IκBα: Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha, NFATc1: Nuclear factor of activated T cells c1, TRAP: Tartrate-resistant acid phosphatase, SEM: Scanning electron microscope, CTSK: Cathepsin K, CTR: Calcitonin receptor, DC-STAMP: Dendritic cell-specific transmembrane protein, TRAF6: Tumor necrosis factor receptor-associated factor 6, AP-1: Activator protein-1


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1433    
    Printed24    
    Emailed0    
    PDF Downloaded124    
    Comments [Add]    

Recommend this journal